CLINICAL_TRIALS
research
· 2018-03-23
Clinical Trial Update: Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms. [NA]
Summary
This clinical trial update describes evaluation of intragen fractional radiofrequency with the NeuViVa system for vaginal laxity and urogynecology symptoms, wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SHERRY Thomas | Conditions: Vaginal Laxity, Urinary Incontinence | NA | Status: UNKNOWN